STOUGHTON, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conference in November:
The Jefferies 2019 London Healthcare Conference on Thursday, November 21st in London. Management will present at 2:00 p.m. GMT and will also participate in investor meetings. About Collegium Pharmaceutical, Inc.Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.
Alex Dasalla
adasalla@collegiumpharma.com
Bay Street News